Actively Recruiting
Echocardiographic Predictors of Atrial Fibrillation
Led by Karl Landsteiner University of Health Sciences · Updated on 2023-03-08
200
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
Sponsors
K
Karl Landsteiner University of Health Sciences
Lead Sponsor
N
NÖ Landesgesundheitsagentur, legal entity of University Hospitals in Lower Austria
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective study aims to identify the diagnostic accuracy of echocardiographic predictors of atrial fibrillation in patients with ESUS (embolic stroke of undetermined source) or TIA (transient ischemic attack).
CONDITIONS
Official Title
Echocardiographic Predictors of Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Written informed consent to participate in the study
- Clinical diagnosis of ischemic stroke or transient ischemic attack (TIA) with brain imaging to exclude hemorrhagic stroke
- For stroke: ESUS defined by non-lacunar stroke on CT or MRI without major-risk cardioembolic sources or significant arterial stenosis
- For TIA: Clinical symptoms lasting less than 1 hour and fulfilling stroke criteria except ischemic lesion detection is optional
- Underwent electrocardiogram, transthoracic or transesophageal echocardiography, and at least 24 hours of cardiac rhythm monitoring
- Patent foramen ovale is allowed
- Planned or existing implantable cardiac monitor or pacemaker is allowed
You will not qualify if you...
- History of atrial fibrillation (AF) or AF detected on 12-lead ECG or during any heart rhythm monitoring before study inclusion
- Poor quality echocardiogram preventing measurement of key parameters for LaHAsPa-Score calculation
- Wearing time of ECG monitor less than 1 week (less than 168 hours) due to withdrawal, patch issues, or technical problems
- Life expectancy less than 1 month
- Patients under custody or unable to give written informed consent due to mental incapacity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tulln
Tulln, Austria, 3430
Actively Recruiting
Research Team
E
Erol Erdik, MD
CONTACT
S
Susanne Holak, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here